Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F   Choi Brian G   Fuster Valentin   Badimon Juan J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis

By Giaginis Costas   Margeli Alexandra   Theocharis Stamatios  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1561-1572

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer

By Fenner Martin H   Elstner Elena  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 557-568

Informa Healthcare

Access to resources Recommend Favorite

Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Advanced Glycation End-product (AGE)-induced Monocyte Chemoattractant Protein-1 Expression in Mesangial Cells Through Downregulation of Receptor for AGEs via Peroxisome Proliferator-activated Receptor-γ Activation

By Matsui T   Yamagishi S   Ueda S   Nakamura K   Imaizumi T   Takeuchi M   Inoue H  

The Journal of International Medical Research, Vol. 35, Iss. 4, 2007-07 ,pp. : 482-489

Field House Publishing

Access to resources Recommend Favorite

Recent Advances in Peroxisome Proliferator-Activated Receptor Science

By  

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 267-280

Bentham Science Publishers

Access to resources Recommend Favorite